{"nct_id":"NCT00319332","title":"A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen","status":"WITHDRAWN","status_verified_date":"2015-04","start_date":"2005-09","start_date_type":null,"primary_completion_date":"2021-02","primary_completion_date_type":"ESTIMATED","completion_date":"2021-02","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GSK"]}